Delcath Systems Competitors and Similar CompaniesClear all

Delcath Systems's competitors and similar companies include OncoStem Diagnostics, CollPlant, Leap Therapeutics and BeyondSpring.
Delcath Systems
Delcath Systems
Delcath Systems is a specialty pharmaceutical and medical device company focused on oncology.
OncoStem Diagnostics
OncoStem Diagnostics
OncoStem Diagnostics is a diagnostic oncology company focused on discovering and developing novel tests for improved treatment planning.
CollPlant
CollPlant
CollPlant Biotechnologies is a medicine company that develops technologies and products for tissue regeneration and organ manufacturing.
Leap Therapeutics
Leap Therapeutics
Leap Therapeutics (also known as Cypherpunk Technologies, formerly known as HealthCare Pharmaceuticals) is a biopharmaceutical company developing targeted and immuno-oncology therapeutics.
BeyondSpring
BeyondSpring
BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies.
Founding Date
Founding Date
1988
Founding Date
2011
Founding Date
1981
Founding Date
2011
Founding Date
2010
Type
Type
Public
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
New York, US HQ
Galway, IE
Queensbury, US
Locations
Bengaluru, IN HQ
Locations
Rehovot, IL HQ
Locations
Cambridge, US HQ
Locations
Florham Park, US HQ
Employees
Employees
437% decrease
Employees
24
Employees
5724% decrease
Employees
688% decrease
Employees
4014% increase
Valuation ($)
Valuation ($)
294.6 m
Valuation ($)
N/A
Valuation ($)
44.9 m
Valuation ($)
176.4 m
Valuation ($)
89.4 m

Financial

Revenue (est.)
Revenue (est.)
$85.2m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
$2.4m (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
$11.8m (FY, 2025)
Cost of goods
N/A
Cost of goods
$835k (FY, 2025)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
$73.4m (FY, 2025)
Gross profit
N/A
Gross profit
$1.5m (FY, 2025)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
$2.7m (FY, 2025)
Net income
N/A
Net income
($11.5m) (FY, 2025)
Net income
$4.8m (FY, 2025)
Net income
($16.7m) (FY, 2024)

Funding

Total funding raised
Total funding raised
$ 42m
Total funding raised
$ 7m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 36.1m
For sources of this data, please see the company profile

View Company Profiles

OncoStem Diagnostics
HQ
Bengaluru, IN
Employees
24

OncoStem Diagnostics is a diagnostic oncology company focused on discovering and developing novel tests for improved treatment planning.

View company
CollPlant
HQ
Rehovot, IL
Employees
57↓ 24% decrease

CollPlant Biotechnologies is a medicine company that develops technologies and products for tissue regeneration and organ manufacturing.

View company
Leap Therapeutics
HQ
Cambridge, US
Employees
6

Leap Therapeutics (also known as Cypherpunk Technologies, formerly known as HealthCare Pharmaceuticals) is a biopharmaceutical company developing targeted and immuno-oncology therapeutics.

View company
BeyondSpring
HQ
Florham Park, US
Employees
40↑ 14% increase

BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies.

View company